Idenix Pharmaceuticals Overview

  • Year Founded
  • 1998

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 65

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $3.9B

Idenix Pharmaceuticals General Information

Description

Operator of a biopharmaceutical company engaged in the discovery and development of drugs to treat human viral diseases. The company utilizes its specialties in nucleoside chemistry and other small molecule chemistries to develop antiviral pharmaceuticals. The company's current focus is on the treatment of patients with hepatitis C infection.

Contact Information

Formerly Known As
Novirio Pharmaceuticals, Novirio Pharmaceuticals Ltd
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 60 Hamphire Street
  • Cambridge, MA 02139
  • United States
+1 (617)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Pharmaceuticals
Acquirer
Vertical(s)
Corporate Office
  • 60 Hamphire Street
  • Cambridge, MA 02139
  • United States
+1 (617)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Idenix Pharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Merger/Acquisition 05-Aug-2014 $3.9B Completed Generating Revenue
8. PIPE 28-Jan-2014 Completed Generating Revenue
7. 2PO 26-Oct-2005 Completed Generating Revenue
6. 2PO 25-Oct-2005 Completed Generating Revenue
5. IPO 22-Jul-2004 Completed Generating Revenue
4. IPO 16-Dec-2002 Cancelled Generating Revenue
3. Later Stage VC (Series C) 01-Jun-2001 Completed Generating Revenue
2. Early Stage VC (Series B) 01-Aug-1999 $12.4M $24.6M Completed Generating Revenue
1. Early Stage VC (Series A) 01-Jun-1998 $12.3M $12.3M Completed Product Development
To view Idenix Pharmaceuticals’s complete valuation and funding history, request access »

Idenix Pharmaceuticals Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a biopharmaceutical company engaged in the discovery and development of drugs to treat human viral diseases.
Drug Discovery
Cambridge, MA
65 As of 2014

Foster City, CA
 

Durham, NC
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Idenix Pharmaceuticals Competitors (20)

One of Idenix Pharmaceuticals’s 20 competitors is Gilead, a Formerly VC-backed company based in Foster City, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Gilead Formerly VC-backed Foster City, CA
BioCryst Pharmaceuticals Corporation Durham, NC
Innate Pharma Formerly VC-backed Marseille, France
Astellas Pharma Corporation Tokyo, Japan
Immunocore Holdings Formerly VC-backed Abingdon, United Kingdom
You’re viewing 5 of 20 competitors. Get the full list »

Idenix Pharmaceuticals Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Idenix Pharmaceuticals Former Investors (16)

Investor Name Investor Type Holding Investor Since Participating Rounds
Adage Capital Management Hedge Fund Minority
BB Biotech Asset Manager Minority
Bank of America Investment Bank Minority
Brookside Capital Venture Capital Minority
Credit Suisse Investment Bank Minority
You’re viewing 5 of 16 investors. Get the full list »

Idenix Pharmaceuticals FAQs

  • When was Idenix Pharmaceuticals founded?

    Idenix Pharmaceuticals was founded in 1998.

  • Where is Idenix Pharmaceuticals headquartered?

    Idenix Pharmaceuticals is headquartered in Cambridge, MA.

  • What is the size of Idenix Pharmaceuticals?

    Idenix Pharmaceuticals has 65 total employees.

  • What industry is Idenix Pharmaceuticals in?

    Idenix Pharmaceuticals’s primary industry is Drug Discovery.

  • Is Idenix Pharmaceuticals a private or public company?

    Idenix Pharmaceuticals is a Private company.

  • What is the current valuation of Idenix Pharmaceuticals?

    The current valuation of Idenix Pharmaceuticals is .

  • What is Idenix Pharmaceuticals’s current revenue?

    The current revenue for Idenix Pharmaceuticals is .

  • How much funding has Idenix Pharmaceuticals raised over time?

    Idenix Pharmaceuticals has raised $576M.

  • Who are Idenix Pharmaceuticals’s investors?

    Adage Capital Management, BB Biotech, Bank of America, Brookside Capital, and Credit Suisse are 5 of 16 investors who have invested in Idenix Pharmaceuticals.

  • Who are Idenix Pharmaceuticals’s competitors?

    Gilead, BioCryst Pharmaceuticals, Innate Pharma, Astellas Pharma, and Immunocore Holdings are some of the 20 competitors of Idenix Pharmaceuticals.

  • When was Idenix Pharmaceuticals acquired?

    Idenix Pharmaceuticals was acquired on 05-Aug-2014.

  • Who acquired Idenix Pharmaceuticals?

    Idenix Pharmaceuticals was acquired by Merck & Co..

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process